Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.839
-0.114 (-11.96%)
At close: Dec 5, 2025, 4:00 PM EST
0.850
+0.011 (1.31%)
After-hours: Dec 5, 2025, 7:38 PM EST
Liminatus Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 2.25 | 0.65 | 1.06 | 0.86 | 0.2 |
| Research & Development | -0 | 2.69 | 3.76 | 1.85 | 3.8 |
| Operating Expenses | 2.25 | 3.33 | 4.82 | 2.71 | 4 |
| Operating Income | -2.25 | -3.33 | -4.82 | -2.71 | -4 |
| Interest Expense | -0.3 | -0.34 | -0.18 | -0.22 | -1.61 |
| Interest & Investment Income | 0.12 | 0.12 | 0.01 | - | - |
| Pretax Income | -2.27 | -3.55 | -4.98 | -2.93 | -5.61 |
| Net Income | -2.27 | -3.55 | -4.98 | -2.93 | -5.61 |
| Net Income to Common | -2.27 | -3.55 | -4.98 | -2.93 | -5.61 |
| Shares Outstanding (Basic) | 116 | 112 | 102 | 36 | - |
| Shares Outstanding (Diluted) | 116 | 112 | 102 | 36 | - |
| Shares Change (YoY) | 181.69% | 9.49% | 188.25% | - | - |
| EPS (Basic) | -0.02 | -0.03 | -0.05 | -0.08 | - |
| EPS (Diluted) | -0.02 | -0.03 | -0.05 | -0.08 | - |
| EBITDA | - | - | - | -2.71 | -4 |
| D&A For EBITDA | - | - | - | 0 | 0 |
| EBIT | -2.25 | -3.33 | -4.82 | -2.71 | -4 |
Source: S&P Capital IQ. Standard template.
Financial Sources.